A study for a 60 year old woman who takes Letrozole - from FDA reports


5,230 females aged 60 (±5) who take the same drug are studied. This is a personalized study for a 60 year old female patient who has Cancer - Breast. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.


Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.




On Oct, 16, 2018

5,230 females aged 60 (±5) who take Letrozole are studied.


Number of reports submitted per year:

Letrozole for a 60-year old woman.

Information of the patient in this study:

  • Age: 60
  • Gender: female
  • Conditions: Cancer - Breast
  • Drugs taken:
    • Letrozole (letrozole)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Joint pain
  2. Fatigue (feeling of tiredness)
  3. Weakness
  4. Bone pain
  5. Diarrhea
  6. Pain in extremity
  7. Muscle aches (muscle pain)
  8. Pain
  9. Nausea and vomiting
  10. Headache (pain in head)
1 - 6 months:
  1. Joint pain
  2. Fever
  3. Pain
  4. Bone disorder
  5. Urinary tract infection
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Toothaches (tooth pain)
  8. Breathing difficulty
  9. Oedema peripheral (superficial swelling)
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
6 - 12 months:
  1. Joint pain
  2. Pain
  3. Fatigue (feeling of tiredness)
  4. Stress and anxiety
  5. Osteonecrosis of jaw (death of bone of jaw)
  6. Pain in extremity
  7. Oedema peripheral (superficial swelling)
  8. Breathing difficulty
  9. Metastases to bone (cancer spreads to bone)
  10. Bone disorder
1 - 2 years:
  1. Malignant neoplasm progression (cancer tumour came back)
  2. Breathing difficulty
  3. Joint pain
  4. Metastases to bone (cancer spreads to bone)
  5. Bone pain
  6. Hair loss
  7. Osteonecrosis of jaw (death of bone of jaw)
  8. Fatigue (feeling of tiredness)
  9. Depression
  10. Interstitial lung disease
2 - 5 years:
  1. Fatigue (feeling of tiredness)
  2. Metastases to liver (cancer spreads to liver)
  3. Malignant neoplasm progression (cancer tumour came back)
  4. Metastases to bone (cancer spreads to bone)
  5. Joint pain
  6. Muscle aches (muscle pain)
  7. Herpes zoster
  8. Hair loss
  9. Bone pain
  10. Weight increased
5 - 10 years:
  1. Metastases to bone (cancer spreads to bone)
  2. Metastases to lung (cancer spreads to lung)
  3. Hair color changes
  4. Hair texture abnormal
  5. Hair disorder
  6. Hair loss
  7. Joint pain
  8. Rash pruritic (redness with itching)
  9. Osteonecrosis of jaw (death of bone of jaw)
  10. Nausea (feeling of having an urge to vomit)
10+ years:
n/a
not specified:
  1. Fatigue (feeling of tiredness)
  2. Nausea (feeling of having an urge to vomit)
  3. Pain
  4. Joint pain
  5. Stress and anxiety
  6. Diarrhea
  7. Weakness
  8. Breathing difficulty
  9. White blood cell count decreased
  10. Back pain

Top conditions involved for these people *:

  1. Metastases To Bone (cancer spreads to bone): 383 people, 7.32%
  2. Breast Cancer Female : 359 people, 6.86%
  3. High Blood Pressure : 217 people, 4.15%
  4. Pain : 195 people, 3.73%
  5. Neoplasm Malignant (cancer tumour): 156 people, 2.98%
  6. Depression : 146 people, 2.79%
  7. High Blood Cholesterol : 112 people, 2.14%
  8. Stress And Anxiety : 110 people, 2.10%
  9. Preventive Health Care : 99 people, 1.89%
  10. Osteoporosis (bones weak and more likely to break): 99 people, 1.89%

Top co-used drugs for these people *:

  1. Ibrance (1,278 people, 24.44%)
  2. Zometa (697 people, 13.33%)
  3. Faslodex (304 people, 5.81%)
  4. Taxotere (299 people, 5.72%)
  5. Aredia (283 people, 5.41%)
  6. Xeloda (280 people, 5.35%)
  7. Aromasin (239 people, 4.57%)
  8. Herceptin (235 people, 4.49%)
  9. Arimidex (227 people, 4.34%)
  10. Tamoxifen Citrate (211 people, 4.03%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?



Related studies:

FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!